Th1 releases anti‐tumor cytokines, such as IFN‐γ, IL‐2, and TNF‐α, and enhances the ability of antigen presentation of DCs via the CD40/CD40L signaling pathway. The gene discussed is IFNG; the disease is neoplasm.